Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Colorectal Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3447
Tytuł:
Association between colorectal cancer, the frequency of Bacteroides fragilis, and the level of mismatch repair genes expression in the biopsy samples of Iranian patients.
Autorzy:
Nazarinejad N; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Hajikhani B; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Vaezi AA; Department of Internal Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Firoozeh F; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Sameni F; Department of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
Yaslianifard S; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Goudarzi M; Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Dadashi M; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran. m_.; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. m_.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Feb 23; Vol. 24 (1), pp. 82. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Colorectal Neoplasms, Hereditary Nonpolyposis*/diagnosis
Colorectal Neoplasms, Hereditary Nonpolyposis*/genetics
Colorectal Neoplasms, Hereditary Nonpolyposis*/pathology
Humans ; DNA Mismatch Repair/genetics ; Bacteroides fragilis/genetics ; Bacteroides fragilis/metabolism ; Iran ; MutS Homolog 2 Protein/genetics ; MutS Homolog 2 Protein/metabolism ; Microsatellite Instability ; DNA-Binding Proteins/genetics ; MutL Protein Homolog 1/genetics ; MutL Protein Homolog 1/metabolism ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China.
Autorzy:
Liu H; Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Xu H; Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Liu Y; Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Zhao Y; Office of Academic Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital and Institute, Beijing, China.
Yu Y; The Clinical Epidemiology of Research Center, Department of Dermatological, The First Affiliated Hospital of Baotou Medical College, Baotou, China.
Du L; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
Liu Y; Office of Shenzhen Cancer Prevention and Control Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Wang W; School of Nursing, Jining Medical University, Jining, China.
Cao H; Department of Preventive Health, Xinxiang Central Hospital, Xinxiang, China.
Ma L; Public Health School, Dalian Medical University, Dalian, China.
Huang J; Department of Gastroenterology, Wuzhou Red Cross Hospital, Wuzhou, China.
Cao J; Department of Cancer Prevention and Control Office, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Li L; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Fan Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Gu X; Department of Student Affairs, Affiliated Tumor Hospital, Xinjiang Medical University, Ürümqi, Xinjiang, China.
Feng C; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.
Zhu Q; School of Public Health and Management, Chongqing Medical University, Chongqing, China.
Wang X; Department of Public Health, Gansu Provincial Cancer Hospital, Lanzhou, China.
Du J; School of Public Health, Chengdu Medical College, Chengdu, China.
Zhang S; Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. .
Qiao Y; Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. .; Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100005, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 20; Vol. 24 (1), pp. 503. Date of Electronic Publication: 2024 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/therapy
Humans ; Middle Aged ; China/epidemiology ; Asian People ; Educational Status
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
Autorzy:
Zhang W; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen L; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Liu J; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen B; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Shi H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Chen H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Qi H; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Wu Z; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Mao X; Department of Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Wang X; Department of Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Huang Y; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Li J; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Yu Z; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China.
Zhong M; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. mkzhong_.
Wang T; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. .
Li Q; Department of Pharmacy, Huashan Hospital, Fudan University, No.12 Urumqi Middle Road, Shanghai, 200040, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 16; Vol. 43 (1), pp. 114. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Brain Neoplasms*
Neoplastic Syndromes, Hereditary*
Humans ; Microsatellite Instability ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Autophagy-Related Protein 7/genetics ; Immunity ; Cholesterol ; DNA Mismatch Repair
SCR Disease Name:
Turcot syndrome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stereotactic ablative brachytherapy versus percutaneous microwave ablation as salvage treatments for lung oligometastasis from colorectal cancer.
Autorzy:
Li Y; Department of Interventional Medicine and Minimally Invasive Oncology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan, 250033, PR of China.; Interventional Oncology Institute, Shandong University, Jinan, PR of China.
Chen Z; Department of Interventional Medicine and Minimally Invasive Oncology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan, 250033, PR of China.
Tian S; Department of Interventional Medicine and Minimally Invasive Oncology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan, 250033, PR of China.
Han X; Interventional Oncology Institute, Shandong University, Jinan, PR of China.; Department of Radiology, Shandong Provincial Hospital, Jinan, PR of China.
Wang C; Interventional Oncology Institute, Shandong University, Jinan, PR of China.; Department of Radiology, People's Hospital of Jiyang County, Jinan, PR of China.
Wang Y; Department of Interventional Medicine and Minimally Invasive Oncology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan, 250033, PR of China.; Interventional Oncology Institute, Shandong University, Jinan, PR of China.
Liu B; Department of Interventional Medicine and Minimally Invasive Oncology, The Second Hospital of Shandong University, No. 247 Beiyuan Street, Jinan, 250033, PR of China. .; Interventional Oncology Institute, Shandong University, Jinan, PR of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 16; Vol. 24 (1), pp. 481. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Brachytherapy*/adverse effects
Colorectal Neoplasms*/radiotherapy
Colorectal Neoplasms*/surgery
Fistula*/surgery
Liver Neoplasms*/surgery
Catheter Ablation*
Humans ; Retrospective Studies ; Salvage Therapy ; Microwaves/adverse effects ; Treatment Outcome ; Lung/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PREX2 contributes to radiation resistance by inhibiting radiotherapy-induced tumor immunogenicity via cGAS/STING/IFNs pathway in colorectal cancer.
Autorzy:
Li M; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.; Jinfeng Laboratory, Chongqing, 401329, People's Republic of China.
Xiao J; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.; Jinfeng Laboratory, Chongqing, 401329, People's Republic of China.
Song S; Department of Pathology, Yantai Fushan People's Hospital, Yantai, 265500, Shandong, People's Republic of China.
Han F; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.; Yue Bei People's Hospital Postdoctoral Innovation Practice Base, Southern Medical University, Guangzhou, 510515, People's Republic of China.
Liu H; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Lin Y; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Ni Y; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Zeng S; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.; Jinfeng Laboratory, Chongqing, 401329, People's Republic of China.
Zou X; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Wu J; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Wang F; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Xu S; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Liang Y; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Xu P; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Hong H; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Qiu J; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Cao J; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Zhu Q; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China.; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China.
Liang L; Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China. .; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, People's Republic of China. .; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, People's Republic of China. .; Jinfeng Laboratory, Chongqing, 401329, People's Republic of China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Apr 12; Vol. 22 (1), pp. 154. Date of Electronic Publication: 2024 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Apoptosis*
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/radiotherapy
Animals ; Mice ; Humans ; CD8-Positive T-Lymphocytes ; Disease Models, Animal ; Gene Expression ; Guanine Nucleotide Exchange Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
Autorzy:
Elez E; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. .
Cubillo A; Centro Integral, Oncológico Clara Campal, HM CIOCC, Madrid, Spain.; Facultad HM Hospitales de Ciencias de La Salud UCJC, 28050, Madrid, Spain.
Alfonso PG; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain.
Middleton MR; Department of Oncology, NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Chau I; Gastrointestinal Unit, Royal Marsden Hospital, London & Surrey, UK.
Alkuzweny B; Formerly Pfizer, Inc, San Diego, CA, USA.
Alcasid A; Pfizer Inc, Collegeville, PA, USA.
Zhang X; Pfizer, Inc, New York, NY, USA.
Van Cutsem E; University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 11; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article
MeSH Terms:
Nivolumab*/therapeutic use
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Benzimidazoles*
Humans ; Ipilimumab ; Mutation ; Microsatellite Repeats ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer.
Autorzy:
Chen H; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Wang C; Department of Pathology, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.
Chen Z; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Huang T; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Lin Y; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Chen J; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China.; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China.
Zhang B; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China. .
He X; Department of General Surgery (Colorectal Surgery), The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510655, China. .; Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Road, Guangzhou, Guangdong, 510655, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 433. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Peripheral Nerves*/pathology
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/surgery
Humans ; Prognosis ; Retrospective Studies ; Disease-Free Survival ; Neoplasm Invasiveness/pathology ; Neoplasm Staging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic factors associated with early recurrence following liver resection for colorectal liver metastases: a systematic review and meta-analysis.
Autorzy:
Tian Y; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.
Wang Y; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.
Wen N; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.
Wang S; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China.
Li B; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China. .; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China. .
Liu G; Department of General Surgery, Division of Biliary Surgery, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China. .; Research Center for Biliary Diseases, West China Hospital, Sichuan University, Sichuan, Chengdu, 610041, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 426. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Colorectal Neoplasms*/surgery
Colorectal Neoplasms*/pathology
Liver Neoplasms*/pathology
Humans ; Hepatectomy ; Prognosis ; Prospective Studies ; Reproducibility of Results ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Barriers and facilitators to implementing a multilevel, multicomponent intervention promoting colorectal cancer screening in health centers: a qualitative study of key informant perspectives.
Autorzy:
Telles VM; Joint Doctoral Program in Public Health at San Diego State University, University of California, San Diego, USA. .
Rodriguez S; Department of Anthropology, University of California, Riverside, Riverside, USA.
Torres M; Joint Doctoral Program in Public Health at San Diego State University, University of California, San Diego, USA.
Schneider J; School of Public Health, San Diego State University Research Foundation, San Diego, USA.
Haughton J; Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, USA.
Maldonado M; School of Public Health, San Diego State University Research Foundation, San Diego, USA.
Arredondo E; School of Public Health, San Diego State University Research Foundation, San Diego, USA.; Psychology Department, San Diego State University, San Diego, USA.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2024 Mar 29; Vol. 24 (1), pp. 404. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Journal Article
MeSH Terms:
Early Detection of Cancer*/methods
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/prevention & control
Humans ; Delivery of Health Care ; Hispanic or Latino ; Health Personnel ; Mass Screening
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-cell transcriptional signature-based drug repurposing and in vitro evaluation in colorectal cancer.
Autorzy:
Mahdi-Esferizi R; Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Shiasi Z; Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Heidari R; Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Najafi A; Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mahmoudi I; Information Technology Department, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Elahian F; Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Tahmasebian S; Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 25; Vol. 24 (1), pp. 371. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Repositioning*/methods
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Dicarboxylic Acids*
Fatty Acids*
Humans ; HT29 Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib.
Autorzy:
Li H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Feng H; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang T; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu J; Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shen X; Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xu L; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang S; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang Y; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jia W; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ji X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Cheng X; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Zhao R; Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 21; Vol. 23 (1), pp. 59. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
MicroRNAs*/genetics
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Indoles*
Quinolines*
Humans ; Animals ; Mice ; RNA, Circular/genetics ; Tumor Suppressor Protein p53 ; Prospective Studies ; Cell Proliferation/genetics ; Biomarkers ; Ubiquitin Thiolesterase/metabolism ; Cyclins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Perceived communication efficacy and unmet needs for chemotherapy-associated symptom management in patients with lung and colorectal cancer: a cross-sectional study.
Autorzy:
Zeng K; School of Nursing, Southern Medical University, No.1023-1063 Shatai South Road, Baiyun District, Guangzhou, 510515, China.
Zhong Y; Peter MacCallum Cancer Centre, Melbourne, Australia.
Chen X; The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Zhang L; School of Nursing, Southern Medical University, No.1023-1063 Shatai South Road, Baiyun District, Guangzhou, 510515, China. zhanglili_.
Pokaż więcej
Źródło:
BMC palliative care [BMC Palliat Care] 2024 Mar 13; Vol. 23 (1), pp. 71. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/complications
Colorectal Neoplasms*/drug therapy
Antineoplastic Agents*/adverse effects
Humans ; Cross-Sectional Studies ; Surveys and Questionnaires ; Communication ; Lung ; Health Services Needs and Demand ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Regulation of metastatic potential by drug repurposing and mitochondrial targeting in colorectal cancer cells.
Autorzy:
Mathur S; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Srivastava P; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Srivastava A; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Rai NK; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Abbas S; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Kumar A; Department of Surgical Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India.
Tiwari M; Department of Biochemistry, All India Institute of Medical Sciences, Patna Bihar, 801507, India.
Sharma LK; Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Rae Bareli Road, (U.P.), Lucknow, 226014, India. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 08; Vol. 24 (1), pp. 323. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Colonic Neoplasms*/metabolism
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Animals ; Humans ; Tigecycline/metabolism ; Tigecycline/pharmacology ; Drug Repositioning ; Cell Line, Tumor ; Mitochondria/metabolism ; Anti-Bacterial Agents/pharmacology ; Cell Proliferation ; Apoptosis ; Adenosine Triphosphate/metabolism ; Mammals/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Downregulation of SMOC1 is associated with progression of colorectal traditional serrated adenomas.
Autorzy:
Aoki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.; Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.; Department of Gastroenterology and Endoscopy, Koyukai Shin-Sapporo Hospital, Sapporo, Japan.
Takasawa A; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yamamoto E; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Niinuma T; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Yamano HO; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Harada T; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.; Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.
Kubo T; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yorozu A; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Kitajima H; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Ishiguro K; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Kai M; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan.
Katanuma A; Center for Gastroenterology, Teine-Keijinkai Hospital, Sapporo, Japan.
Shinohara T; Department of Pathology, Teine-Keijinkai Hospital, Sapporo, Japan.
Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Sugai T; Department of Molecular Diagnostic Pathology, Iwate Medical University, Morioka, Japan.
Osanai M; Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, S1, W17, Chuo-Ku, Sapporo, 060-8556, Japan. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Mar 01; Vol. 24 (1), pp. 91. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Adenoma*/genetics
Adenoma*/pathology
Colonic Polyps*/pathology
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Humans ; Down-Regulation ; Hyperplasia ; Osteonectin ; Proto-Oncogene Proteins B-raf/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Autorzy:
Pennel KAF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK. .
Hatthakarnkul P; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Wood CS; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Lian GY; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Al-Badran SSF; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Quinn JA; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Legrini A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Inthagard J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Alexander PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
van Wyk H; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Kurniawan A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Hashmi U; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; University of Glasgow Medical School, Glasgow, G12 8QQ, UK.
Gillespie MA; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Mills M; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Ammar A; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Hay J; Glasgow Tissue Research Facility, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Andersen D; Bioclavis Ltd, Glasgow, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Nixon C; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Rebus S; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Chang DK; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Kelly C; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Harkin A; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Graham J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, Glasgow, G12 0XH, UK.
Church D; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Tomlinson I; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XU, UK.
Saunders M; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK.
Iveson T; Southampton University Hospital NHS Foundation Trust, Southampton, SO16 6YD, UK.
Lannagan TRM; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Jackstadt R; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Maka N; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Horgan PG; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Roxburgh CSD; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Sansom OJ; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
McMillan DC; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.
Steele CW; Department of Surgery, Glasgow Royal Infirmary, Glasgow, G31 2ER, UK.; CRUK Scotland Institute, Glasgow, G61 1BD, UK.
Jamieson NB; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Park JH; Department of Surgery, Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK.
Roseweir AK; University of Glasgow Medical School, Glasgow, G12 8QQ, UK.
Edwards J; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, G61 1QH, UK.
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 01; Vol. 43 (1), pp. 64. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Humans ; Animals ; Mice ; Retrospective Studies ; Signal Transduction ; Hypoxia ; Keratins/metabolism ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Cell Line, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma.
Autorzy:
Beirat AF; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, 11941, Jordan.
Amarin JZ; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, 11941, Jordan.
Suradi HH; Istishari Hospital, Amman, 11184, Jordan.
Qwaider YZ; Department of General and Gastrointestinal Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Muhanna A; Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, MO, 64110, USA.
Maraqa B; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, 11941, Jordan.
Al-Ani A; Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, 11941, Jordan.
Al-Hussaini M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, 11941, Jordan. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2024 Feb 28; Vol. 19 (1), pp. 44. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Colorectal Neoplasms*/pathology
Adenocarcinoma*/pathology
Humans ; Neoplasm Staging ; Lymph Node Ratio ; Lymphatic Metastasis/pathology ; Lymph Nodes/pathology ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
Autorzy:
Smabers LP; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Wensink E; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Verissimo CS; HUB Organoids B.V, Utrecht, The Netherlands.
Koedoot E; HUB Organoids B.V, Utrecht, The Netherlands.
Pitsa KC; HUB Organoids B.V, Utrecht, The Netherlands.
Huismans MA; Molecular Cancer Research, Center for Molecular Medicine, UMCU, Utrecht, The Netherlands.
Higuera Barón C; HUB Organoids B.V, Utrecht, The Netherlands.
Doorn M; HUB Organoids B.V, Utrecht, The Netherlands.
Valkenburg-van Iersel LB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
Cirkel GA; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
Brousali A; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.
Overmeer R; HUB Organoids B.V, Utrecht, The Netherlands.
Koopman M; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Braat MN; Department of Radiology, UMCU, Utrecht, The Netherlands.
Penning de Vries B; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Vries RG; HUB Organoids B.V, Utrecht, The Netherlands.
Kranenburg O; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.; Laboratory of Translational Oncology, Division of Imaging and Cancer, UMCU, Utrecht, The Netherlands.
Boj SF; HUB Organoids B.V, Utrecht, The Netherlands. .
Roodhart JM; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 27; Vol. 43 (1), pp. 61. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colonic Neoplasms*/drug therapy
Humans ; Irinotecan/pharmacology ; Irinotecan/therapeutic use ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Acetylcysteine/therapeutic use ; Precision Medicine ; Fluorouracil/pharmacology ; Fluorouracil/therapeutic use ; Organoids ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The frequency of colorectal lesions in the first-degree relatives of patients with colorectal lesions among PERSIAN Guilan Cohort Study population (PGCS).
Autorzy:
Matin S; Department of Internal Medicine, School of Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
Joukar F; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Razi Hospital, Sardar-Jangle Ave, 41448-95655, Rasht, Iran.
Maroufizadeh S; Department of Biostatistics and Epidemiology, School of Health, Guilan University of Medical Sciences, Rasht, Iran.
Asgharnezhad M; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Razi Hospital, Sardar-Jangle Ave, 41448-95655, Rasht, Iran.
Karimian P; Department of Pathology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Mansour-Ghanaei F; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Razi Hospital, Sardar-Jangle Ave, 41448-95655, Rasht, Iran. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Feb 26; Vol. 24 (1), pp. 88. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Colonic Polyps*/epidemiology
Colonic Polyps*/genetics
Colonic Polyps*/diagnosis
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/diagnosis
Humans ; Middle Aged ; Cross-Sectional Studies ; Iran/epidemiology ; Prospective Studies ; Cohort Studies ; Colonoscopy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CT-guided radioactive I seeds brachytherapy for lung oligometastases from colorectal cancer: initial results.
Autorzy:
Song M; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Zhou X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Hou R; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Sigdel M; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Liu Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Zhang C; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Xu K; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Han X; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China.
Jiao D; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 26; Vol. 24 (1), pp. 265. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*/adverse effects
Brachytherapy*/methods
Colorectal Neoplasms*/radiotherapy
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Neoplasm Staging ; Carcinoembryonic Antigen ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; Lung/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
Autorzy:
Jin Y; Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Str, Harbin, 150001, People's Republic of China. .
Jiang A; Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Str, Harbin, 150001, People's Republic of China.
Sun L; Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Str, Harbin, 150001, People's Republic of China.
Lu Y; Department of Gastroenterology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Str, Harbin, 150001, People's Republic of China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 21; Vol. 24 (1), pp. 238. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Cyclic N-Oxides*
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Thymopoietins*/genetics
Thymopoietins*/metabolism
Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Glucose ; Glycolysis/genetics ; Nuclear Proteins/genetics ; RNA, Antisense/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3447

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies